Molecular and chromosomal alterations: new therapies for relapsed acute myeloid leukemia

By Palmisano Michela   Grafone Tiziana   Renzulli Matteo   Ottaviani Emanuela   Testoni Nicoletta   Paolini Stefania   Papayannidis Cristina   Baccarani Michele   Martinelli Giovanni  

Hematology, Vol. 13, Iss. 1, 2008-02 ,pp. : 1-12

Maney Publishing

Access to resources Recommend Favorite

Apoptosis and immaturity in acute myeloid leukemia

By Del Principe Maria Ilaria   Del Poeta Giovanni   Venditti Adriano   Buccisano Francesco   Maurillo Luca   Mazzone Carla   Bruno Antonio   Neri Benedetta   Irno Consalvo Maria   Lo Coco Francesco   Amadori Sergio  

Hematology, Vol. 10, Iss. 1, 2005-02 ,pp. : 25-34

Maney Publishing

Access to resources Recommend Favorite

Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia

By Greiner J.   Ringhoffer M.   Taniguchi M.   Schmitt A.   Kirchner D.   Krahn G.   Heilmann V.   Gschwend J.   Bergmann L.   Dohner H.   Schmitt M.  

Experimental Hematology, Vol. 30, Iss. 9, 2002-09 ,pp. : 1029-1035

Elsevier

Access to resources Recommend Favorite

Serum leptin level in acute myeloid leukemia patients

By Yilmaz M.   Kis C.   Ceylan N. O.   Okan V.   Pehlivan M.   Kuçukosmanoglu E.   Yilmaz F.   Tarakcioglu M.  

Hematology, Vol. 13, Iss. 1, 2008-02 ,pp. : 21-23

Maney Publishing

Access to resources Recommend Favorite

Efficacy and resistance of gemtuzumab ozogamicin for acute myeloid leukemia

By Takeshita Akihiro  

International Journal of Hematology, Vol. 97, Iss. 6, 2013-06 ,pp. : 703-716

Springer Publishing Company

Access to resources Recommend Favorite